VPC 44116
| Catalog Number | BL-M000992 |
| CAS Number | 925978-30-9 |
| Description | VPC 44116, a novel therapeutic compound, demonstrates significant promise in combatting diabetes and obesity through its role as a specific agonist of the EP4 receptor, providing potent anti-inflammatory and anti-fibrotic effects. Preclinical investigations suggest that VPC 44116 may hold potential for ameliorating insulin resistance and metabolic complications. |
 | |
| IUPAC Name | [(3R)-3-amino-4-(3-octylanilino)-4-oxobutyl]phosphonic acid |
| Synonyms | (R)-(3-amino-4-((3-octylphenyl)amino)-4-oxobutyl)phosphonic acid |
| Molecular Weight | 370.42 |
| Molecular Formula | C18H31N2O4P |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 58.36%, H 8.44%, N 7.56%, O 17.28%, P 8.36% |
| Canonical SMILES | CCCCCCCCC1=CC(=CC=C1)NC(=O)C(CCP(=O)(O)O)N |
| InChI | InChI=1S/C18H31N2O4P/c1-2-3-4-5-6-7-9-15-10-8-11-16(14-15)20-18(21)17(19)12-13-25(22,23)24/h8,10-11,14,17H,2-7,9,12-13,19H2,1H3,(H,20,21)(H2,22,23,24)/t17-/m1/s1 |
| InChI Key | FMLHSOGKNHADEE-QGZVFWFLSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry